Overview Treatment of Peripheral T-cell Lymphoma Status: Completed Trial end date: 2016-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of GDPT regiment (gemcitabine，cisplatin,Prednisone ,Thalidomide ) for patients with Peripheral T-cell lymphoma. Phase: Phase 4 Details Lead Sponsor: Mingzhi ZhangCollaborator: Zhengzhou UniversityTreatments: CisplatinCyclophosphamideDoxorubicinGemcitabinePrednisolonePrednisoneThalidomideVincristine